These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15898150)

  • 1. Music still playing for the LDL limbo.
    Harv Heart Lett; 2005 May; 15(9):6. PubMed ID: 15898150
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic values of various markers in evaluation of patients with chest pain.
    David DS
    Am J Cardiol; 2009 May; 103(9):1329-30. PubMed ID: 19406283
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation.
    Sanchis J; Bosch X; Bodí V; Bellera N; Núñez J; Benito B; Ordóñez J; Consuegra L; Heras M; Llècer A
    Heart; 2008 Mar; 94(3):311-5. PubMed ID: 17639094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-infarction risk is higher with low LDL? Pondering global risk, treatment bias and the nature of outcome events.
    Wexler O; Schwartz RG
    Cardiol J; 2009; 16(3):195-6. PubMed ID: 19437392
    [No Abstract]   [Full Text] [Related]  

  • 5. [The apoB/apoA-I ratio is better myocardial infarction marker than lipids].
    Walldius G; Angelin B; Eriksson M
    Lakartidningen; 2006 Mar 8-14; 103(10):751-2. PubMed ID: 16610201
    [No Abstract]   [Full Text] [Related]  

  • 6. Seasonal variation in serum cholesterol levels may be another explanation for seasonal variation in acute myocardial infarction.
    Cheng TO
    Int J Cardiol; 2005 Sep; 104(1):101. PubMed ID: 16137517
    [No Abstract]   [Full Text] [Related]  

  • 7. I've heard that a measurement called apo B may be better a predicting heart attacks than LDL cholesterol levels. Should I be tested for apo B?
    Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):8. PubMed ID: 15602781
    [No Abstract]   [Full Text] [Related]  

  • 8. Exertional chest pain.
    Rivera ML; Nadel ES; Brown DF
    J Emerg Med; 2005 Jan; 28(1):69-73. PubMed ID: 15657008
    [No Abstract]   [Full Text] [Related]  

  • 9. Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction.
    Al-Mallah MH; Hatahet H; Cavalcante JL; Khanal S
    Cardiol J; 2009; 16(3):227-33. PubMed ID: 19437396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary prevention of patients with ischaemic heart disease--the reduction of LDL cholesterol level and the regression of atherosclerosis].
    Bárczi G; Merkely B
    Lege Artis Med; 2007 Oct; 17(10):675-9. PubMed ID: 19227597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
    Rudling M
    Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659
    [No Abstract]   [Full Text] [Related]  

  • 13. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A doctor talks about LDL cholesterol.
    Robb-Nicholson C
    Harv Womens Health Watch; 2004 Nov; 12(3):3. PubMed ID: 15556896
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognostic implictions of the lack of a lipid-lowering strategy].
    Baessler A; Fischer M; Hubauer U; Stark K; Hengstenberg W; Wiedmann S; Neureuther K; Holmer S; Mayer B; Schunkert H; Hengstenberg C
    MMW Fortschr Med; 2006 Nov; 148(44):38. PubMed ID: 17619439
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain.
    Sanchis J; Bodí V; Núñez J; Bertomeu V; Consuegra L; Bosch MJ; Gómez C; Bosch X; Chorro FJ; Llácer A
    Am J Cardiol; 2006 Oct; 98(7):885-9. PubMed ID: 16996867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL-cholesterol level provides additional prognosis in acute coronary syndromes.
    Correia LC; Rocha MS; Esteves JP
    Int J Cardiol; 2009 Aug; 136(3):307-14. PubMed ID: 18706714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coronary heart disease patient after myocardial infarct. Must LDL cholesterol now be reduced to 70 mg/dl?]].
    MMW Fortschr Med; 2005 Dec; 147(49-50):17-8. PubMed ID: 16401004
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction.
    Farwell WR; Sesso HD; Buring JE; Gaziano JM
    Am J Cardiol; 2005 Oct; 96(8):1129-34. PubMed ID: 16214451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.